Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for elderly post-noncardiac surgery ICU patients
NCT04204798Active, not recruiting
- Sponsor
- Peking University First Hospital
- Start
- Aug 2020
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in postoperative delirium (POD) and sleep disorder, sponsored by Peking University First Hospital. Primary endpoint: Overall Survival at 4 years. Started Aug 2020; status: active, not recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)sleep disorder
Beyond the preview
Go deeper on NCT04204798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04204798.